Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colony stimulating factor augmentation in human placental conditioned medium.

D S Verma1, G Spitzer, M Beran

  • 1Department of Developmental Therapeutics, The University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, 6723 Bertner Avenue, Houston, TX 77030, USA.

Experimental Hematology
|August 1, 1980
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT.

Bone marrow transplantation·2017
Same author

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines.

Blood cancer journal·2014
Same author

Evaluation of BM cytomorphology after allo-SCT in patients with MDS.

Bone marrow transplantation·2012
Same author

Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

Bone marrow transplantation·2012
Same author

Evaluation of BM cytomorphology after allo-SCT in patients with AML.

Bone marrow transplantation·2012
Same author

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.

Bone marrow transplantation·2011

Researchers enhanced colony-stimulating factor (CSF) production from human placental conditioned media (HPCM) using endotoxin and bacillus Calmette Guerin (BCG). This method improves CSF yield for clinical applications and purification.

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Human placental conditioned media (HPCM) is a source of colony-stimulating factor (CSF).
  • Placental variability affects CSF production, necessitating methods for consistent yield.
  • Existing HPCM batches show significant variability in their ability to stimulate colony formation.

Purpose of the Study:

  • To augment colony-stimulating factor (CSF) elaboration in human placental conditioned media (HPCM).
  • To investigate the efficacy of endotoxin and bacillus Calmette Guerin (BCG) in enhancing CSF production.
  • To assess the impact of augmentation on the types of cell colonies formed.

Main Methods:

  • Prepared 14 batches of HPCM from different placentas.
  • Assessed the colony-stimulating activity of HPCM batches using human marrow cells.

Related Experiment Videos

  • Augmented CSF elaboration in selected HPCM batches using endotoxin or BCG during incubation.

    • Main Results:

    • Six HPCM batches were inactive, five were weak stimulators, and three were active.
    • Augmentation with endotoxin or BCG markedly increased CSF elaboration in all tested cases.
    • Increased colony formation was primarily due to enhanced neutrophil and macrophage colonies.

    Conclusions:

    • Augmentation with endotoxin or BCG effectively increases CSF production from HPCM.
    • This method offers a way to produce large quantities of potent and standardized CSF.
    • The approach has significant implications for clinical laboratory use and CSF purification.